The putative blood-brain barrier transporter for the beta-amyloid binding protein apolipoprotein j is saturated at physiological concentrations.

No abstract is available for this paper.

• Publication year

  1997

• Venue

  Life Science

• Publication date

  1997-01-10

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1016/S0024-3205(96)00685-6PMID 9042383
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Apolipoprotein J and Alzheimer's amyloid beta solubility.

  1996cited by this paper
• Passage of human amyloid beta-protein 1-40 across the murine blood-brain barrier.

  1994cited by this paper
• The soluble form of Alzheimer's amyloid beta protein is complexed to high density lipoprotein 3 and very high density lipoprotein in normal human plasma.

  1994cited by this paper
• Passage of human amyloid β-protein 1–40 across the murine blood-brain barrier

  1994cited by this paper
• Brain uptake of circulating apolipoproteins J and E complexed to Alzheimer's amyloid beta.

  1994cited by this paper
• The cerebrospinal-fluid soluble form of Alzheimer's amyloid beta is complexed to SP-40,40 (apolipoprotein J), an inhibitor of the complement membrane-attack complex.

  1993cited by this paper
• Blood-brain barrier transport of circulating Alzheimer's amyloid beta.

  1993cited by this paper
• Isolation of Low‐Molecular‐Weight Proteins from Amyloid Plaque Fibers in Alzheimer's Disease

  1986cited by this paper
• Alzheimer's disease: Initial report of the purification and characterization of a novel cerebrovascular amyloid protein

  1984cited by this paper
• Measurements of dog blood-brain transfer constants by ventriculocisternal perfusion.

  1975cited by this paper

• Vascular models of Alzheimer's disease: An overview of recent in vitro models of the blood-brain barrier.

  2025cites this paper
• Alzheimer’s disease-associated complement gene variants influence plasma complement protein levels

  2023cites this paper
• Interactions of Lipids, Lipoproteins, and Apolipoproteins with the Blood-Brain Barrier

  2021cites this paper
• Diagnosing Alzheimer’s Disease from Circulating Blood Leukocytes Using a Fluorescent Amyloid Probe

  2021cites this paper
• Can platelet activation result in increased plasma Aβ levels and contribute to the pathogenesis of Alzheimer's disease?

  2021cites this paper
• Diabetes Mellitus Related to Diseases of the Exocrine Pancreas (Pancreatogenic Diabetes)

  2021cites this paper
• Platelet APP Processing: Is It a Tool to Explore the Pathophysiology of Alzheimer’s Disease? A Systematic Review

  2021cites this paper
• Clusterin as a Potential Biomarker of Obesity-Related Alzheimer’s Disease Risk

  2020cites this paper
• Secreted Chaperones in Neurodegeneration

  2020cites this paper
• ApoE elevation is associated with the persistence of psychotic experiences from age 12 to age 18: Evidence from the ALSPAC birth cohort.

  2019cites this paper
• Decoding the Role of Platelets and Related MicroRNAs in Aging and Neurodegenerative Disorders

  2019cites this paper
• Elimination of substances from the brain parenchyma: efflux via perivascular pathways and via the blood–brain barrier

  2018cites this paper
• Rate of small‐molecular drug transport across the blood‐brain barrier in a pericyte‐deficient state

  2018influential citation
• Blood-Brain Barriers in Obesity

  2017cites this paper
• Platelets are responsible for the accumulation of β-amyloid in blood clots inside and around blood vessels in mouse brain after thrombosis.

  2017cites this paper
• Apolipoproteins and their subspecies in human cerebrospinal fluid and plasma

  2017cites this paper
• Lymphatics in Neurological Disorders: A Neuro-Lympho-Vascular Component of Multiple Sclerosis and Alzheimer's Disease?

  2016cites this paper
• Title : Platelets are responsible for the accumulation of β ‐ amyloid in blood clots inside and around blood vessels in mouse brain after thrombosis

  2016cites this paper
• Brain Effect Site Pharmacokinetics: Delivery of Biologics Across the Blood–Brain Barrier

  2015cites this paper
• The Potential of Pathological Protein Fragmentation in Blood-Based Biomarker Development for Dementia – With Emphasis on Alzheimer’s Disease

  2015cites this paper
• In silico, in vitro and in vivo methods to analyse drug permeation across the blood-brain barrier: A critical review

  2013cites this paper
• In Vitro Blood-Brain Barrier Models Using Brain Capillary Endothelial Cells Isolated from Neonatal and Adult Rats Retain Age-Related Barrier Properties

  2013cites this paper
• Clusterin in Alzheimer's disease.

  2012cites this paper
• Lipoproteins and Apolipoproteins in Alzheimer's Disease

  2012cites this paper
• Drug delivery to the brain in Alzheimer's disease: consideration of the blood-brain barrier.

  2012cites this paper
• Identification of Peptide Ligands for Targeting to the Blood-Brain Barrier

  2010cites this paper
• Lipids and Cognition

  2010cites this paper
• Insulin detemir is not transported across the blood-brain barrier.

  2010cites this paper
• Differentielle Analyse des HDL-Proteoms mittels Massenspektrometrie

  2010cites this paper
• Minimal penetration of lipopolysaccharide across the murine blood-brain barrier.

  2010cites this paper
• Author ' s personal copy Lipopolysaccharide alters the blood – brain barrier transport of amyloid b protein : A mechanism for inflammation in the progression of Alzheimer ’ s disease

  2009cites this paper
• Clearance of amyloid-beta peptide across the blood-brain barrier: implication for therapies in Alzheimer's disease.

  2009cites this paper
• Chapter 7: Cell protective functions of secretory Clusterin (sCLU).

  2009cites this paper
• Lipopolysaccharide alters the blood-brain barrier transport of amyloid beta protein: a mechanism for inflammation in the progression of Alzheimer's disease.

  2009cites this paper
• Clearance of amyloid-β peptide across the blood-brain barrier: Implication for therapies in Alzheimer’s disease

  2009cites this paper
• The blood-brain barrier in health and chronic neurodegenerative disorders.

  2008cites this paper
• Effects of triglycerides, obesity, and starvation on ghrelin transport across the blood-brain barrier.

  2008cites this paper
• Aβ peptides can enter the brain through a defective blood–brain barrier and bind selectively to neurons

  2007cites this paper
• Role of A β Transport and Clearance in the Pathogenesis and Treatment of Alzheimer’s Disease

  2007cites this paper
• Channels across Endothelial Cells

  2006cites this paper
• Red cell interactions with amyloid-beta(1-40) fibrils in a murine model.

  2005cites this paper
• Red cell interactions with amyloid-β1-40 fibrils in a murine model

  2005cites this paper
• Links Between the Pathology of Alzheimer's Disease and Vascular Dementia

  2004cites this paper
• Triglycerides induce leptin resistance at the blood-brain barrier.

  2004cites this paper
• Developmentally regulated mannose 6-phosphate receptor-mediated transport of a lysosomal enzyme across the blood-brain barrier.

  2004cites this paper
• Passage of murine scrapie prion protein across the mouse vascular blood-brain barrier.

  2004cites this paper
• Efficient transfer of receptor-associated protein (RAP) across the blood-brain barrier

  2004cites this paper
• Binding, internalization, and membrane incorporation of human immunodeficiency virus-1 at the blood-brain barrier is differentially regulated.

  2004cites this paper
• Permeability of the mouse blood-brain barrier to murine interleukin-2: predominance of a saturable efflux system.

  2004cites this paper
• Red cell perturbations by amyloid beta-protein.

  2003cites this paper
• Red cell perturbations by amyloid β-protein

  2003cites this paper
• Cerebrospinal fluid Abeta40 and Abeta42: natural course and clinical usefulness.

  2002cites this paper
• Circulating amyloid-beta peptide crosses the blood-brain barrier in aged monkeys and contributes to Alzheimer's disease lesions.

  2002cites this paper
• Differential Transport of a Secretin Analog across the Blood-Brain and Blood-Cerebrospinal Fluid Barriers of the Mouse

  2002cites this paper
• Cerebrospinal fluid Aβ40 and Aβ42: Natural course and clinical usefulness

  2001cites this paper
• Normal levels of clusterin in cerebrospinal fluid in Alzheimer's disease, and no change after acute ischemic stroke

  2001cites this paper
• Diagnosis of CAA during Life

  2000cites this paper
• Constitutive overactivation of protein kinase C in guinea pig brain increases α‐secretory APP processing without decreasing β‐amyloid generation

  2000cites this paper
• Mechanisms of Cerebrovascular Amyloid Deposition: Lessons from Mouse Models

  2000cites this paper
• Molecular assembly of endogenous and synthetic big atrial natriuretic peptide (ANP) and its amyloidogenic implications.

  2000cites this paper
• Constitutive overactivation of protein kinase C in guinea pig brain increases alpha-secretory APP processing without decreasing beta-amyloid generation.

  2000cites this paper
• Clearance of Alzheimer's amyloid-ss(1-40) peptide from brain by LDL receptor-related protein-1 at the blood-brain barrier.

  2000cites this paper
• Permeability of the blood-brain barrier to albumin and insulin in the young and aged SAMP8 mouse.

  2000cites this paper
• Development of an In Situ Mouse Brain Perfusion Model and its Application to mdr1a P-Glycoprotein-Deficient Mice

  2000cites this paper
• Apolipoprotein J (clusterin) and Alzheimer's disease

  2000cites this paper
• Partial saturation and regional variation in the blood-to-brain transport of leptin in normal weight mice.

  2000cites this paper
• Receptor-mediated transport of human amyloid beta-protein 1-40 and 1-42 at the blood-brain barrier.

  1999cites this paper
• Neuronal overexpression of mutant amyloid precursor protein results in prominent deposition of cerebrovascular amyloid.

  1999cites this paper
• APP Isoforms in Platelets

  1998cites this paper
• Human blood-brain barrier receptors for Alzheimer's amyloid-beta 1- 40. Asymmetrical binding, endocytosis, and transcytosis at the apical side of brain microvascular endothelial cell monolayer.

  1998cites this paper
• Differential level of platelet amyloid beta precursor protein isoforms: an early marker for Alzheimer disease.

  1998cites this paper
• Can blood-brain barrier play a role in the development of cerebral amyloidosis and Alzheimer's disease pathology.

  1997cites this paper
• Interactions of β‐Amyloids with the Blood–Brain Barrier

  1997cites this paper